These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Potassium stimulation of aldosterone secretion in vivo is reversed by nisoldipine, a calcium transport antagonist. Johnson EI; McDougall JG; Coghlan JP; Denton DA; Scoggins BA; Wright RD Endocrinology; 1984 Apr; 114(4):1466-8. PubMed ID: 6705743 [TBL] [Abstract][Full Text] [Related]
26. A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart disease. Silke B; Verma SP; Midtbo KA; Müller P; Frais MA; Reynolds G; Taylor SH Int J Cardiol; 1986 Nov; 13(2):231-41. PubMed ID: 3793280 [TBL] [Abstract][Full Text] [Related]
27. Effect of calcium antagonist compound nisoldipine on transepithelial electrical parameters in the isolated frog cornea. Wiederholt M; Zadunaisky JA J Ocul Pharmacol; 1986; 2(2):159-64. PubMed ID: 3509727 [TBL] [Abstract][Full Text] [Related]
28. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects. Laederach K; Weidmann P; Lauener F; Gerber A; Ziegler WH J Cardiovasc Pharmacol; 1986; 8(2):294-302. PubMed ID: 2422467 [TBL] [Abstract][Full Text] [Related]
29. Silent myocardial ischemia: improvement with nisoldipine therapy. Glasser SP; Arce-Weston B; Clark PI South Med J; 1989 Jan; 82(1):32-4, 46. PubMed ID: 2643167 [TBL] [Abstract][Full Text] [Related]
30. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. Schrör K; Latta G; Darius H; Klaus W; Ziegler R Klin Wochenschr; 1985 Jan; 63(1):16-9. PubMed ID: 3838352 [TBL] [Abstract][Full Text] [Related]
31. Effects of amlodipine on steady-state digoxin concentrations and renal digoxin clearance. Schwartz JB J Cardiovasc Pharmacol; 1988 Jul; 12(1):1-5. PubMed ID: 2459525 [TBL] [Abstract][Full Text] [Related]
32. Monotherapy with the calcium channel antagonist nisoldipine for systemic hypertension and comparison with diuretic drugs. Daniels AR; Opie LH Am J Cardiol; 1987 Sep; 60(8):703-7. PubMed ID: 3661439 [TBL] [Abstract][Full Text] [Related]
33. [Effects of m-nisoldipine and nisoldipine on hemodynamics in anesthetized dogs]. Fu SX; Li YS; Jing CJ; Ren LM Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):43-8. PubMed ID: 3188933 [No Abstract] [Full Text] [Related]
34. Inhibition of phospholipase A2 (PLA2) activity by nifedipine and nisoldipine is independent of their calcium-channel-blocking activity. Chang J; Blazek E; Carlson RP Inflammation; 1987 Sep; 11(3):353-64. PubMed ID: 3115895 [TBL] [Abstract][Full Text] [Related]
36. The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow. Meredith PA; Pasanisi F; Elliott HL; Reid JL Br J Clin Pharmacol; 1985 Sep; 20(3):235-7. PubMed ID: 4041344 [TBL] [Abstract][Full Text] [Related]
37. [Interaction of the calcium antagonists nifedipine and nisoldipine with the nondepolarizing muscle relaxant vecuronium bromide in an vivo rat preparation]. Ilias W; Steinbereithner K Anaesthesist; 1985 Nov; 34(11):588-90. PubMed ID: 2868675 [TBL] [Abstract][Full Text] [Related]
38. The calcium antagonist nisoldipine stimulates the electrolyte transport of the isolated frog skin. Wiederholt M; Keller S; Krolik A; Jentsch TJ Biochem Pharmacol; 1984 Sep; 33(18):2926-8. PubMed ID: 6332628 [No Abstract] [Full Text] [Related]
39. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension. Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339 [TBL] [Abstract][Full Text] [Related]
40. Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. Konrad-Dalhoff I; Baunack AR; Rämsch KD; Ahr G; Kraft H; Schmitz H; Weihrauch TR; Kuhlmann J Eur J Clin Pharmacol; 1991; 41(4):313-6. PubMed ID: 1804645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]